Few Childhood Cancer Survivors Get Recommended ScreeningsMarch 25, 2024PediatricsPatient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell Lymphoma
Most Cancer Trial Centers Located Closer to White, Affluent PopulationsMarch 21, 2024Patient & Survivor CareDLBCLMixed TopicsPediatricsAggressive LymphomasALLAML
New Drug Approvals Are the Wrong Metric for Cancer PolicyMarch 20, 2024Mixed TopicsDLBCLPediatricsPatient & Survivor CareAggressive LymphomasALLAML
Extraordinary Patients Inspired Father of Cancer ImmunotherapyMarch 19, 2024Mixed TopicsPatient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell Lymphoma
Consider These Factors in an Academic Radiation Oncology PositionMarch 14, 2024Aggressive LymphomasALLAMLB Cell LymphomaBusiness of MedicineCLLCML
Look Beyond BMI: Metabolic Factors’ Link to Cancer ExplainedMarch 14, 2024Patient & Survivor CareDLBCLALLAggressive LymphomasAMLB Cell LymphomaCLL
ASTRO Pushes Return to Direct Supervision in RT: Needed or ‘Babysitting’?March 13, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaBusiness of Medicine
High Marks for New CAR T Toxicity Grading ToolMarch 12, 2024Cellular TherapyB Cell LymphomaDLBCLMantle Cell LymphomaMultiple MyelomaTransplantMixed Topics
FDA Removes Harmful Chemicals From Food PackagingMarch 1, 2024Mixed TopicsPediatricsBusiness of MedicineDLBCLAggressive LymphomasALLAML
FDA Withdraws Melflufen Approval, but EMA Still Allows Its UseFebruary 29, 2024Multiple MyelomaPatient & Survivor Care
Are Food Emulsifiers Associated With Increased Cancer Risk?February 23, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
